Fallon Wellness Pharmacy Recalls Methylcobolamin Injections Due to Sterility Concerns
Fallon Wellness Pharmacy is recalling 56 vials of Methylcobolamin injections in New York due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls involving significant injury or property damage reports, or in this context, a critical sterility failure for an injectable drug, align with a Severe rating (Score 4), as it poses a significant risk of serious health consequences such as infection.
Plain-English summary
Fallon Wellness Pharmacy, L.L.C. is recalling 56 vials of Methylcobolamin injections in various concentrations. The recall was initiated because of a lack of assurance of sterility for the product.
The affected product was distributed in New York. The recall involves specific lots with expiration dates ranging from March 14, 2015, to April 6, 2015.
Consumers who have this product should stop using it and contact their healthcare provider or the pharmacy for further instructions.
The recalled product
- Product
- Methylcobolamin 1) 6500 mcg/0.26mL, 2) 1000 mcg/0.08mL, 3) 5000mcg/mL, 4) 3000mcg/0.12mL, 5) 4000mcg/0.16mL, 6) 1000mcg/mL and 7) 1000 mcg/0.04mL injection, Fallon Wellness Pharmacy, L.L.C., Latham, NY 12110
- Manufacturer
- Fallon Wellness Pharmacy, L.L.C.
- Category
- Drug — Injectable
- Affected units
- 56
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- Lot#: a) 02052015@53
- Exp 4/6/15
- b) 01142015@31
- Exp 3/15/15
- c) 02022015@6
- Exp 4/3/15
- d) 01132015@72
- Exp 3/14/15
- e) 01282015@57
- Exp 3/29/15
- f) 01302015@50
- Exp 3/31/15
- g) 01232015@14
- Exp 3/24/15
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 10 recalled by Fallon Wellness Pharmacy, L.L.C. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Fallon Wellness Pharmacy, L.L.C.
See all →- SevereFallon Wellness Pharmacy Recalls Papaverine Injection Due to Sterility Concerns
FDA (Drugs) · 2016-12-14
- SevereFallon Wellness Pharmacy Recalls PAPA/PHEN/PROST Injection Due to Sterility Concerns
FDA (Drugs) · 2016-12-14
- SevereFallon Wellness Pharmacy Recalls Papaverine Injection Due to Sterility Concerns
FDA (Drugs) · 2015-05-20
- SevereFallon Wellness Pharmacy Recalls Prostaglandin Rx Injections Due to Sterility Concerns
FDA (Drugs) · 2015-05-20
- SevereFallon Wellness Pharmacy Recalls Methylcobalamin/B-Complex Injection Due to Sterility Concerns
FDA (Drugs) · 2015-05-20
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- HighMethylcobalamin Injectable Recall Due to Facility Sterility Assurance Failure
FDA (Drugs) · 2023-02-01
- SevereGreen Valley Drugs Recalls Methylcobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereEssential Wellness Recalls Methylcobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SeverePromise Pharmacy Recalls Methylcobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2019-02-20
- SevereVitalab Methylcobalamin Injection Recalled Due to Sterility Concerns
FDA (Drugs) · 2018-05-16
- SeverePromise Pharmacy Recalls Methylcobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-02-20